검색어 : 통합검색[Sigurdsson Einar M.]
총 129건 중 129건 출력
, 4/13 페이지
-
31
- New directions towards safer and effective vaccines for Alzheimer's disease.
- Goñ i, Fernando; Sigurdsson, Einar M; ; (Current opinion in molecular therapeutics, v.7, 2005, pp.17-23)
-
32
- Mechanistic Studies of Antibody-Mediated Clearance of Tau Aggregates Using an <i>ex vivo</i> Brain Slice Model
- Krishnamurthy, Pavan K.; Deng, Yan; Sigurdsson, Einar M.; Department of Physiology and Neuroscience, New York University School of Medicine New York, NY, USA; Skirball Institute of Biomolecular Medicine, New York University School of Medicine New York, NY, USA; Department of Physiology and Neuroscience, New York University School of Medicine New York, NY, USA; (Frontiers in psychiatry, v.2, 2011, pp.59)
-
33
- A safer vaccine for Alzheimer’s disease?
- Sigurdsson, Einar M; Wisniewski, Thomas; Frangione, Blas; ; (Neurobiology of aging, v.23, 2002, pp.1001-1008)
-
34
- Amyloid-β targeting immunisation in aged non-human primate (<i>Microcebus murinus</i>)
- G. Trouche Stéphanie; Boutajangout Allal; Asuni Ayodeji; Fontés Pascaline; Sigurdsson Einar M.; Verdier Jean-Michel; Mestre-Francés Nadine; ; (, v., 2022, )
-
35
- Infectivity of amyloid diseases
- Sigurdsson, Einar M; Wisniewski, Thomas; Frangione, Blas; ; (Trends in molecular medicine, v.8, 2002, pp.411-413)
-
36
- Single-Domain Antibody-Based Protein Degrader for Synucleinopathies
- Jiang Yixiang; Lin Yan; Tetlow Amber M.; Pan Ruimin; Ji Changyi; Kong Xiang-Peng; Congdon Erin E.; Sigurdsson Einar M.; ; (, v., 2024, )
-
37
- Passive τ immunotherapy diminishes functional decline and clears τ aggregates in a mouse model of tauopathy
- Boutajangout, Allal; Ingadottir, Johanna; Davies, Peter; Sigurdsson, Einar M.; ; (Alzheimer's & dementia : the journal of the Alzheimer's Association, v.6, 2010, pp.S578)
-
38
- Diminished Amyloid-β Burden in Tg2576 Mice Following a Prophylactic Oral Immunization with a Salmonella-Based Amyloid-β Derivative Vaccine
- Boutajangout Allal; Goni Fernando; Knudsen Elin; Schreiber Fernanda; Asuni Ayodeji; Quartermain David; Frangione Blas; Chabalgoity Alejandro; Wisniewski Thomas; Sigurdsson Einar M.; Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Immunology, School of Chemistry, University of Uruguay, Montevideo, Uruguay; Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Biotechnology, School of Medicine, University of Uruguay, Montevideo, Uruguay; Department of Psychiatry, New York University School of Medicine, New York, NY, USA; Department of Neurology, New York University School of Medicine, New York, NY, USA; Department of Pathology, New York University School of Medicine, New York, NY, USA; Department of Biotechnology, School of Medicine, University of Uruguay, Montevideo, Uruguay; Department of Pathology, New York University School of Medicine, New York, NY, USA; Department of Psychiatry, New York University School of Medicine, New York, NY, USA; (Journal of Alzheimer''s Disease, v.18, 2009, pp.961-972)
-
39
- Passive tau immunotherapy diminishes functional decline and clears tau aggregates in a mouse model of tauopathy
- Boutajangout, Allal; Ingadottir, Johanna; Davies, Peter; Sigurdsson, Einar M.; NYU School of Medicine, New York, NY, USA; NYU School of Medicine, New York, NY, USA; Albert Einstein College of Medicine, Bronx, NY, USA; NYU School of Medicine, New York, NY, USA; (Alzheimer's & dementia : the journal of the Alzheimer's Association, v.6, 2010, pp.S578-S578)
-
40
- Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
- Banka Vinay; Kelleher Andrew; Sehlin Dag; Hultqvist Greta; Sigurdsson Einar M.; Syvänen Stina; Ding Yu-Shin; ; (Frontiers in Nuclear Medicine, v., 2023, )
QUICK MENU
